|
⚲
|
| Keyboard |
| Violin Jonathan
✚
|
|
|---|---|
| CIK # | 0001730615 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001730615] | |
| 4 | [0001730615] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Violin Jonathan | |
| Crescent Biopharma Inc | |
| Dianthus Therapeutics Inc /DE/ | |
| Catabasis Pharmaceuticals Inc | |
| Miragen Therapeutics Inc | |
| Trevena Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 263,321 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,166 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
|
Crescent Biopharma Inc CBIO
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Grant | 9,023 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 26,550 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2025-05-22 | Grant | 12,500 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 14,100 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 11,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2023-09-11 | Grant | 6,500 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 14,100 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2023-02-02 | Sell | 50,000 | $36.80 | 1,840,000 |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 8,333 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-06-01 | Sell | 30,000 | $12.20 | 366,000 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-05-02 | Sell | 30,000 | $13.04 | 391,200 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-04-04 | Sell | 3,600 | $18.93 | 68,148 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-04-01 | Sell | 26,400 | $18.92 | 499,488 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-03-02 | Sell | 11,106 | $17.36 | 192,800 |
| showing 20 of 37 most recent transactions | |||||